ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Live / Registered — Registered — Section 8 accepted (as of 17 Nov 2025)
What this means for you
Registered since 19 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87636178
- Registration number
- 5677678
- Mark type
- Design + words
- Filed
- 06 Oct 2017
- Published for opposition
- 27 Mar 2018
- Registered
- 19 Feb 2019
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 041 — Education and entertainment services: Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases
Owner
- Sanofi Biotechnology, Gentilly, FR
- Sanofi Biotechnology, 75008 Paris, FR
- Sanofi Biotechnology, 75008 Paris, FR
Prosecution history
- 17 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 17 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 08 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2025 — TEAS SECTION 8 RECEIVED
- 19 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 11 Jan 2019 — TTAB RELEASE CASE TO TRADEMARKS
- 11 Jan 2019 — OPPOSITION TERMINATED NO. 999999
- 11 Jan 2019 — OPPOSITION DISMISSED NO. 999999
- 23 May 2018 — OPPOSITION INSTITUTED NO. 999999
- 26 Apr 2018 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 Mar 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Mar 2018 — PUBLISHED FOR OPPOSITION